Chemical study of the Chinese medicine Pi Han Yao
- Authors:
- Published online on: January 7, 2016 https://doi.org/10.3892/br.2016.566
- Pages: 219-222
Abstract
Introduction
Pi Han Yao is a traditional Chinese herbal medicine, derived from the Gueldenstaedtia delavayi Franch plant (1). It was first termed ‘Pi Han Yao’ in the early 1970s in the Xichang Chinese Herbal Medicine book (2). As a Panzhihua-Xichang region folk medicine, Pi Han Yao is mainly used to treat exogenous diseases and has been found to be safe and effective in treating fevers, headaches, dizziness, sore throat, gasping syndrome and cough. The whole dry plant is used, and is usually consumed in a decoction daily. Although there have been studies on the fat-soluble components of the Gueldenstaedtia delavayi Franch plant, the pharmacologically active mechanisms for the effectiveness of Pi Han Yao in treating exogenous diseases remain to be elucidated. In addition, the full chemical constituents of Pi Han Yao have yet to be elucidated and there have been no studies on the quantitative determination of the formononetin and maackiain content, which are essentially the active components of the plant. Therefore, the present study investigated the material basis and mechanisms of the Chinese medicine Pi Han Yao by determining the chemical constituents of the plant decoction. Seven flavanone compounds were isolated from the Pi Han Yao decoction. Based on spectrum analysis, 5 of the 7 were identified. The 5 identified chemical structures were 1, 7,2′-dihydroxy-4′-methoxy-isoflavanol; 2, maackiain; 3, formononetin-7-O-β-D-glucoside; 4, formononetin; and 5, 9-(β-D-ribofuranosyl)-adenosine. To the best of our knowledge, this is the first time that these compounds have been isolated from Pi Han Yao. Further study is required to identify the other 2 compounds and establish their structures. Formononetin, 1 of the 7 compounds isolated from the Pi Han Yao water solution, has been shown to have estrogen-like effects (3,4), antioxidation effects (5), and it can stimulate the specific adaptive immune system (5,6). This compound has also been reported to have beneficial effects for certain cancers, as well as antiatheroscloresis, and diuresis effects (7,8). Maackiain also has a strong diuresis effect, and therefore, formononetin and maackiain were chosen as the index components in the quantitative measurement of Pi Han Yao (9).
Materials and methods
Plant materials
The plant material was identified as Gueldenstaedtia delavayi Franch by Professor Guihua Jiang.
Chemicals
The formononetin standard was purchased from Chengdu at Staples Biological Technology Co., Ltd. (Chendgu, China; batch no. 111703–201012). The maackiain standard was prepared by us to a purity of 99.5%, as previously described (10).
The chromogenic agent, 10% sulfuric acid ethanol and iodine steam, was purchased from Chengdu Kelon (Chengdu, China). Methanol and acetonitrile with chromatographic purification were from Fisher Scientific (Schwerte, Germany). Distilled water was used and all the reagents were of analytical grade.
Instrumentation and conditions
The following instruments were used in the study: Bruker Avance 600 probe: 13C-1H DUL TE: 300K (Bruker, Zurich, Switzerland); Zabspec (Micromass, Waters Corp., Manchester, UK); Rotary Evaporators RE-52 (Shanghai Yarong Biochemistry Instrument Plant, Shanghai, China); Ultraviolet Instrument ZF-2 (Shanghai Anting Electron Instrument Plant, Shanghai, China); high performance liquid chromatography (HPLC; Agilent 1200 HPLC; Agilent Technologies, Inc., Santa Clara, CA, USA); Dikma C18 chromatography column (5 µm, 4.6×250 mm; Dikma, Beijing, China); and a X24 Digital display micro-melting point tester (Beijing Tech Instrument Co., Ltd., Beijing, China).
Silica gel column chromatography (200–300 mesh; Qingdao Oceanic Chemical Plant, Qingdao, China); high-performance thin-layer chromatography (HPTLC; Qingdao Oceanic Chemical Plant); thin-layer chromatography (TLC) silica gel G and silica gel GF254 (Qingdao Oceanic Chemical Plant); and Sephadex LH20 (Pharmacia, Uppsala, Sweden) were used.
Extraction and isolation
The whole dry plants of Pi Han Yao (12 kg) were extracted with 120 liters of water at 90°C three times, 30 min each time, and subsequently concentrated under vacuum to the 30 liters. Following this, the water extract was extracted with ethyl acetate (EtOAc) and n-butanol (n-BuOH), successively. The EtOAc and n-BuOH layers were concentrated to 64.1 and 141.7 g of residues, respectively, and were subsequently separated by repeated chromatography yielding 7 flavanone compounds.
Results
Investigating the chemical constituent of Pi Han Yao Structural determination
Compound 1White needles (methanol); melting point (mp), 195–197°C; [α]D20+210° (c 0.10, methanol), exhibited a positive reaction to the ferric chloride-ferricyanatum kalium test. 1H-nuclear magnetic resonance (NMR): δ:3.56 (1H, m, H-3), 3.63 (3H, s, OCH3–4′), 3.78 (1H, t, J=10.26 Hz, H-2a), 4.29 (1H, dd, J=10.98, 5.16 Hz, H-2a), 5.62 (1H, d, J=7.02 Hz, H-4), 6.37 (1H, d, J=2.4 Hz, H-8), 6.56 (1H, dd, J=2.22, 8.04 Hz, H-5′), 6.67 (1H, d, J=2.22 Hz, H-3′), 6.86 (1H, d, J=2.22 Hz, H-8), 6.94 (1H, dd, J=8.10, 2.58 Hz, H-6), 7.20 (1H, d, J=8.40 Hz, H-6′), 7.58 (1H, d, J=8.40 Hz, H-5). 13C-NMR: δ162.6 (C-4′), δ162.4 (C-2′), δ161.5 (C-7), δ158.4 (C-9), δ133.8 (C-5), δ126.3 (C-, 6′), δ121.0 (C-1′), δ112.9 (C-10), δ111.9 (C-6), δ107.5 (C-5′), δ105.2 (C-8), δ98.2 (C-3′), δ80.2 (C-4), δ67.7 (C-2), δ41.0 (C-3) and δ56.3 (C-OCH3). Compound 1 was identified as 7,2′-dihydroxy-4′-methoxy-isoflavanol by comparison of Heteronuclear Single Quantum Correlation, H-H-Correlation Spectroscopy and Distortionless Enhancement by Polarisation Transfer data (11,12).
Compound 2Colorless needles (methanol, pyridine) reacted positively to FeCl3. The compound was purple-red when exposed to the UV lamp (254 nm), mp180–181°C (12); 1H-NMR:δ7.53 (1H, d, J=8.82 Hz, H-1), 6.90 (1H, dd, J=8.46, 2.16 Hz, H-2), 6.84 (1H, s, H-7); δ6.83 (1H, d, J=2.22 Hz, H-4), 6.64 (1H, s, H-10), 5.91 (1H, d, J=1.14 Hz, −OCH2O-aH); 5.88 (1H, d, J=1.14 Hz, −OCH2O-bH), 5.57 (1H, d, J=7.32 Hz, H-11 a, 4.25 (1H, dd, J=11.04, 4.74 Hz, H-6β), 3.77 (1H, t, J=10.62 Hz, H-6α), 3.48 (1H, m, H-6a). 13C-NMR: δ40.5 (C-6a), 66.5 (C-6), 79.0 (C-11a), 93.7 (C-10), 101.5 (−OCH2-O), 104.0 (C-4), 105.3 (C-7), 110.7 (C-2), 111.8 (C-11b), 118.7 (C-6b), 132.5 (C-1), 141.9 (C-8), 148.3 (C-9), 154.7 (C-10a), 157.3 (C-4a), 160.4 (C-3). Mass spectrometry (MS): m/z: 307 [M+Na], m/z: 285 [M+H]. Compound 2 was identified as maackiain by comparison (1H-NMR and 13C-NMR) with previous data (13,14).
Compound 3White needles (methanol) that were easily soluble in methanol, mp217–219°C. 1H-NMR: δ:8.42 (1H, s, H-2), 8.04 (1H, d, J=8.76 Hz, H-5), 7.52 (2H, d, J=8.40 Hz, H-2′, 6′), 7.23 (1H, s, H-8), 7.13 (1H, d, J=8.82 Hz, H-6), 6.98 (2H, d, J=8.40 Hz, H-3′, 5′), 5.09 (1H, d, J=6.96 Hz, glc H-1′), 3.30 (3H, s, OCH3). δ4.5–5.5: Glycosidic bond −OH, δ3–4 glycosidic bond −H. 13C-NMR: δ175.1 (C-4), δ161.9 (C-7), δ159.5 (C-4′), δ157.5 (C-9), δ154.1 (C-2), δ130.5 (C-2′, 6′), δ127.4 (C-5), δ124.5 (C-1′), δ123.9 (C-3), δ119.0 (C-10), δ116.1 (C-6), δ114.1 (C-3′5′), δ103.9 (C-8), δ100.5 (C-1′), δ77.7 (C-3′), δ77.0 (C-5′), δ73.6 (C-2′), δ70.1 (C-4′), δ61.1 (C-6′), δ55.6 (C-OCH3). Compound 3 was identified as formononetin-7-O-β-D-glucoside by comparison (1H-NMR and 13C-NMR) with previous data (15).
Compound 4White needles (methanol), mp257–258°C; showed a positive reaction to the ferric chloride-ferricyanatum kalium test. 1H-NMR: δ:8.30 (1H, s, H-2), 7.95 (1H, dd, J=8.76,2.22 Hz, H-5), 7.49 (2H, d, J=8.40 Hz, H-2′, 6′), 6.96 (1H, d, J=8.76 Hz, H-3′, 5′), 6.92 (1H, dd, J=8.76, 2.22 Hz, H-6), 6.85 (2H, d, J=2.22 Hz, H-8), 3.77 (3H, s, OCH3). 13C-NMR: δ175.1 (C-4), δ163.0 (C-4′), δ159.4 (C-7), δ157.9 (C-9), δ153.8 (C-3), δ130.5 (C-2′, 6′), δ127.8 (C-5), δ124.7 (C-1′), δ123.6 (C-2), δ117.1 (C-10), δ115.6 (C-6), δ114.1 (C-3′5′), δ102.6 (C-8). MS: m/z: 291 [M+Na], m/z: 269 [M+H]. Compound 4 was identified as formononetin by comparison with previous data (11,16).
Compound 5White needles (methanol), soluble in dimethyl sulfoxide; 1H-NMR: δ:8.32 (1H, s, H-8), 8.12 (1H, s, H-2), 7.30 (2H, s, H-NH2), 5.86 (1H, d, J=6.24 Hz, H-1′), 5.00–5.50 (3H, OH-H), 4.59 (1H, m, H-2′), 4.12 (1H, m, H-3′), 3.94 (1H, m, H-4′), 3.65 (1H, m, H-5′), 3.53 (1H, m, H-5′). 13C-NMR: δ156.6 (C-6), δ152.8 (C-2), δ149.6 (C-4), δ140.4 (C-8), δ119.8 (C-5), δ88.4 (C-1′), δ86.4 (C-4′), δ73.9 (C-2′), δ71.1 (C-3′), δ62.2 (C-5′). MS: m/z: 255 [M+Na], m/z: 237 [M+H]. Compound 5 was identified as 9-(β-D-ribofuranosyl)-adenosine by comparison (1H-NMR and 13C-NMR) with literature data (17,18).
The structures of compounds 1–5 are shown in Fig. 1. The structures of compounds 6 and 7 were complex and thus remain to be identified.
Content tests of formononetin and maackiain in Pi Han Yao Chromatographic conditions
The detection of the compounds was performed at 310 nm. Satisfactory separation was obtained with a reverse-phase analytical column (250×4.6 mm, 5 µl, serial no. 8132964) and eluted with a methanol:water solution (70:30, v/v) at a flow rate of 1.0 ml/min. The column temperature was 25°C and the injection volume was 10 µl. Theoretical plate numbers of formononetin and maackiain were >4,000.
Standard solutionsi) Preparation of stock standard solutions: Formononetin and maackiain stock solution were prepared to a final concentration of 0.73 mg/ml in methanol. Chromatograms are shown in Fig. 2A and B.
ii) Sample preparation. The Pi Han Yao powder (3 g) was processed with ultrasonic extraction (power, 300 W; rate, 50 Hz) for 1 h in EtOAc, and subsequently recovered EtOAc in vacuo to yield the extract. The extract was dissolved with methanol in a 10 ml volumetric flask and filtered through a 0.45-µm filter prior to injection. The chromatogram is shown in Fig. 2C.
CalibrationCalibration curves were constructed in the range of 2–20 µl for formononetin and maackiain. The regression equation curves are listed in Table I.
The data showed a linear association between peak areas and concentration over the listed range for formononetin and maackiain. The detection limit was 0.03992–0.3992 µg for formononetin and 0.0292–0.292 µg for maackiain.
Precision and accuracyThe precision of injection was evaluated by performing replicate injections of the sample solution, and the relative standard deviations of formononetin and maackiain were 0.26 and 0.55%, respectively. These results demonstrated that the method was highly precise.
StabilityTo confirm that the standards remained stable over time, the concentrations of the two components were determined at 0, 2, 4, 8, 12 and 24 h, respectively, and the solution remained relatively stable. The RSD values of formononetin and maackiain were maintained at 1.59 and 2.57%, respectively. The stability of the sample solutions was also evaluated in the same manner by determining the concentrations of the two components at 0, 2, 4, 8 and 12 h, respectively. The test solution remained relatively stable. The RSD values of formononetin and maackiain were maintained at 2.18 and 5.98%, respectively.
Recovery studyThe percentage of recovery was determined by adding a known concentration of the formononetin and maackiain standards to selected samples during the extraction process. The amounts added were ~50% of the actual concentration of the samples. The concentration of the formononetin and the maackiain standards in the mixture were subsequently determined using the same methods described for the sample analysis. Without exception, recovery rates of 100.31% were achieved for the compound analyzed.
Quantitative determination of samplesThe formononetin and maackiain contents of Pi Han Yao from plants collected from 10 different sources were determined in the same way as the sample analysis. The results are shown in Table II.
Analysis of the different Pi Han Yao plants from the 10 locations showed that the contents of formononetin and maackiain varied depending on the source. The content of formononetin ranged from 0.576–0.762 µg/g with an average value of 0.6544 µg/g. The content of maackiain ranged from 0.0124–0.0289 µg/g, with an average value of 0.02221 µg/g. Overall the content of the two chemicals in wild Pi Han Yao was generally higher compared to cultivated plants. However, the difference was not significant. Furthermore, the content of formononetin and maackiain in Pi Han Yao was lower compared to the plant itself.
Discussion
To the best of our knowledge, the chemical constituents of the Chinese medicine Pi Han Yao decoction were investigated for the first time in this study. Five flavanone compounds were identified as follows: 1, 7,2′-dihydroxy-4′-methoxy-isoflavanol; 2, maackiain; 3, formononetin-7-O-β-D-glucoside; 4, formononetin; and 5, 9-(β-D-ribofuranosyl)-adenosine. These compounds were obtained from Pi Han Yao for the first time, in accordance with previous studies (19–24).
The result of the formononetin and maackiain contents of Pi Han Yao from 10 different areas is shown in Table II. A method to determine formononetin and maackiain in the Pi Han Yao by HPLC has been reported in the present study, and this method is convenient, efficient, accurate, reliable and provides good replications, and thus, can be used for the quality control of Pi Han Yao.
The formononetin and maackiain contents were scanned from 200 to 400 nm by UV-1100. The maximum absorption wavelength of formononetin was 250 nm, and the maximum absorption wavelengths of maackiain were 310 and 215 nm. In order to determine the formononetin and maackiain content at the same conditions, the detection at 310 nm exhibited high sensitivity and little interference. Therefore, formononetin and maackiain were detected at 310 nm.
In conclusion, the present study examined the extraction efficiency in solvents, the extraction method and the extraction time. The results showed that ethyl acetate ultrasound extraction had the highest extraction efficiency for constituents of Pi Han Yao.
References
|
Editorial Committee of the Flora of China of Chinese Academy of Science. Beijing: Flora of China. Science Press. 2004. | |
|
Province XChbiSC: Xi Chang Chinese Herbal Medicine. 1:Xi Chang: Xi Chang People's Enterprise. 1972. | |
|
Wang WQ, Han ZK, Chen WH and Chen J: The enhancing effect of formononetin on the development of mammary gland in mice and exploration of its mechanism. Journal of Nanjing Agricultural University. 16:191993. | |
|
Xin D, Liu Z, Xue C, et al: Study on estrogen-like effects of formononetin and its correlation with blood lipids. Chinese Journal of Gerontology. 29:23402009. | |
|
Fu N, Liu C, Zhang R, et al: Study on the antioxidation about the flavonoids and triterpene compounds of glycyrrhiza. Pharmacology and Clinics of Chinese Materia Medica. 5:261994. | |
|
Zhang R and Zhengkang H: Explore the effect of flavonoids on immunologic function in mice and β-endorphin level in the blood of mice. Chinese Journal of Immunology. 10:1771994. | |
|
Qu X and Jingdao L: Summarized the recent developments about the flavonoids of Maackia amurensis Rupr. et. Maxim. Journal of Medical Science Yan Bian University. 16:2311993. | |
|
Roberts DW, Doerge DR, Churchwell MI, da Gamboa Costa G, Marques MM and Tolleson WH: Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover). J Agric Food Chem. 52:6623–6632. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Miao K, Zhang J, Dong Y, et al: The advances in the study on chemical components and pharmacological action of Sophora flavescens. Natural Product Research and Development. 13:69–73. 2001. | |
|
Wang CH, Wang Y, Wang GC, et al: Chemical constituents from roots of Millettia speciosa. Chinese Traditional and Herbal Drugs. 39:972–975. 2008.(In Chinese). | |
|
Li HN, Yan H, Pang XY, et al: Study on chemical constituents of flavonoids of Sophora tonkinensis. China Journal of Chinese Materia Medica. 349:282–285. 2009. | |
|
Gomotsang B, Cornelius CWW, Runner RTR, et al: Two new isoflavanoids from Bolusanthus speciosus. Bulletin of the Chemical Society of Ethiopia. 15:1312001. | |
|
Gao D and Ruyi Z: Study on chemical constituents of glycyrhiza yunnanensis from Yunnan province. Chinese Herbal Medicines. 25:507–508. 1994. | |
|
Li Wu Jun, Toshio Miyase, Akira Ueno, et al: Studies on the constituents of Sophora flavesens AITON.II. Chemical and Pharmaceutical Bulletin. 33:3231–3236. 1985. View Article : Google Scholar | |
|
Cui BL, Nakamura M, Kinjo J, et al: Chemical Constituents of Astragali Semen. Chemical and Pharmaceutical Bulletin. 41:178–182. 1993. View Article : Google Scholar | |
|
Song C, Zheng ZLD, et al: Study on the isoflavone compounds of Astragalus membranaceus (Fisch.) Bunge. Chinese Bulletin of Botany. 39:7641997. | |
|
Basílio Janke EM, Limbach HH and Weisz K: Binding of an acetic acid ligand to adenosine: A low-temperature NMR study. J Am Chem Soc. 126:2135–2141. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chenon MT, Pugmire RJ, Grant DM, Panzica RP and Townsend LB: Carbon-13 magnetic resonance. XXV. A basic set of parameters for the investigation of tautomerism im purines. Established from carbon-13 magnetic resonance studies using certain purines and pyrrolo [2,3-d]pyrimidines. J Am Chem Soc. 97:4627–4636. 1975. View Article : Google Scholar : PubMed/NCBI | |
|
Han Y, Gao L and Taibao W: Study on chemical components of essential oil of gueldenstaedtia multiflora bge. Journal of Shanxi College of TCM. 11:18–21. 2010. | |
|
Han Y and Liming G: Study on chemical constituents of gueldenstaedtia multiflora bge. Journal of Shanxi College of TCM. 10:83–84. 2009. | |
|
Li K, Li XM and Wang BG: Chemical from herd of constituents of Gueldenstaedtia stenophylla. Zhongguo Zhong Yao Za Zhi. 33:1711–1713. 2008.(In Chinese). PubMed/NCBI | |
|
Wang J and Rong Z: Study on the chemical constituents of Gueldenstaedtia multiflora Bge. Acta Botanica Boreali-Occidentalia Sinica. 9:127–130. 1989. | |
|
Wei YX, Chen L and Wang JX: Studies on the chemical constituents of Gueldenstaedtia stenophylla. Zhong Yao Cai. 30:954–956. 2007.(In Chinese). PubMed/NCBI | |
|
Zhu Rong ZD and Xu RS: Study on the chemical constituents of Gueldenstaedtia multiflora Bge. Chinese Traditional and Herbal Drugs. 15:1–3. 1984. |
